Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study

References

• Williams N, Covington J S, III. Methamphetamine and meth mouth: an overview. J Tenn Dent Assoc 2006; 86: 32–35
   PubMedGoogle Scholar
• Meredith C W, Jaffe C, Ang-Lee K, Saxon A J. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005; 13: 141–154
   PubMed Web of Science ®Google Scholar
• McKetin R, McLaren J, Lubman D I, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006; 101: 1473–1478
   PubMed Web of Science ®Google Scholar
• Shoptaw S, Peck J, Reback C J, Rotheram-Fuller E. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. J Psychoact Drugs 2003; 35(Suppl. 1)161–168
   PubMed Web of Science ®Google Scholar
• Wang Y, Hayashi T, Chang C F, et al. Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. Stroke 2001; 32: 775–782
   PubMed Web of Science ®Google Scholar
• Smith L, Yonekura M L, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr 2003; 24: 17–23
   PubMed Web of Science ®Google Scholar
• Hong R, Matsuyama E, Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 1991; 265: 1152–1154
   PubMed Web of Science ®Google Scholar
• Lan K C, Lin Y F, Yu F C, Lin C S, Chu P. Clinical manifestations and prognostic features of acute methamphetamine intoxication. J Formos Med Assoc 1998; 97: 528–533
   PubMed Web of Science ®Google Scholar
• Sheridan J, Bennett S, Coggan C, Wheeler A, McMillan K. Injury associated with methamphetamine use: a review of the literature. Harm Reduct J 2006; 3: 14
   PubMedGoogle Scholar
• Rawson R A, Gonzales R, Brethen P. Treatment of methamphetamine use disorders: an update. J Subst Abuse Treat 2002; 23: 145–150
   PubMed Web of Science ®Google Scholar
• Mansergh G, Purcell D W, Stall R, et al. CDC consultation on methamphetamine use and sexual risk behavior for HIV/STD infection: summary and suggestions. Public Health Rep 2006; 121: 127–132
   PubMed Web of Science ®Google Scholar
• Colfax G, Coates T J, Husnik M J, et al. Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. J Urban Health 2005; 82: i62–70
   PubMed Web of Science ®Google Scholar
• Page-Shafer K, Veugelers P J, Moss A R, Strathdee S, Kaldor J M, van Griensven G J. Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982 – 1994. Am J Epidemiol 1997; 146: 531–542
   PubMed Web of Science ®Google Scholar
• Chesney M A, Barrett D C, Stall R. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health 1998; 88: 113–116
   PubMed Web of Science ®Google Scholar
• Hunt D, Kuck S, Truitt L. Methamphetamine use: lessons learned. Report to the US Department of Justice no. 209730; 31 January 2006. Available at: http://www.ncjrs.gov/pdffiles1/nij/grants/209730.pdf (accessed 27 March 2007)
   Google Scholar
• Anglin M D, Perrochet B. Drug use and crime: a historical review of research conducted by the UCLA Drug Abuse Research Center. Subst Use Misuse 1998; 33: 1871–1914
   PubMed Web of Science ®Google Scholar
• Gibson D R, Leamon M H, Flynn N. Epidemiology and public health consequences of methamphetamine use in California's Central Valley. J Psychoact Drugs 2002; 34: 313–319
   PubMed Web of Science ®Google Scholar
• Rutkowski B A. California Substance Abuse Research Consortium, September 2005: update on recent methamphetamine trends in four California regions. J Psychoact Drugs 2006, Suppl. 3: 369–375
   PubMedGoogle Scholar
• Centers for Disease Control. Methamphetamine use and HIV risk behaviors among heterosexual men—preliminary results from five northern California counties, December 2001 – November 2003. MMWR 2006; 55: 273–277
   PubMedGoogle Scholar
• US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies. Treatment episode data set (TEDS). National Admissions to Substance Abuse Treatment Services, Rockville, MD 2005, Available at: http://www.oas.samhsa.gov (accessed 27 March 2007)
   Google Scholar
• US Department of Health and Human Services Substance Abuse (UHDHHS) and Mental Health Services Administration Office of Applied Studies (MHSAOAS). Drug Abuse Warning Network, 2005: national estimates of drug related emergency department visits. DAWN Series. UHDHHS/MHSAOAS, Rockville, MD, Available at: http://DAWNinfo.samhsa.gov/ (accessed 27 March 2007)
   Google Scholar
• US Department of Justice National Institute of Justice. Arrestee drug abuse monitoring program. US Department of Justice, National Institute of Justice, Washington, DC, Available at: http://www.ojp.usdoj.gov/nij/adam/welcome.html (accessed 27 March 2007)
   Google Scholar
• Clements K, Gleghorn A, Garcia D, Katz M, Marx R. A risk profile of street youth in northern California: implications for gender-specific human immunodeficiency virus prevention. J Adolesc Health 1997; 20: 343–353
   PubMed Web of Science ®Google Scholar
• Gleghorn A A, Marx R, Vittinghoff E, Katz M H. Association between drug use patterns and HIV risks among homeless, runaway, and street youth in northern California. Drug Alcohol Depend 1998; 51: 219–227
   PubMed Web of Science ®Google Scholar
• Moon M W, Binson D, Page-Shafer K, Diaz R. Correlates of HIV risk in a random sample of street youths in San Francisco. J Assoc Nurses AIDS Care 2001; 12: 18–27
   PubMedGoogle Scholar
• Kral A H, Lorvick J, Edlin B R. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Def Syndr 2000; 24: 162–167
   PubMed Web of Science ®Google Scholar
• Das-Douglas M, Colfax G, Moss A R, Bangsberg D R, Hahn J A. Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996 – 2003. J Urban Health 2007, Epub ahead of print
   PubMed Web of Science ®Google Scholar
• San Francisco Department of Public Health. Synthesis of data on methamphetamine use in San Francisco. HIV/AIDS statistics and epidemiology section; March 2007. Available at: www.dph.sf.ca.us/sfcityclinic/providers/MethRaymondReport2006.pdf (accessed 9 January 2008).
   Google Scholar
• Hahn J, Page-Shafer K, Lum P, Ochoa K, Moss A. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 2001; 34: 180–187
   PubMed Web of Science ®Google Scholar
• Fairbairn N, Kerr T, Buxton J A, Li K, Montaner J S, Wood E. Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting. Drug Alcohol Depend 2006; 8
   Google Scholar
• Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2005; 2: 194–199
   PubMedGoogle Scholar
• Page-Shafer K, Hahn J A, Lum P J, Ochoa K, Graves A, Moss A. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J Acquir Immune Defic Syndr 2002; 31: 422–431
   PubMed Web of Science ®Google Scholar
• Kral A H, Lorvick J, Ciccarone D, et al. HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San Francisco. J Urban Health 2005; 82: i43–50
   Web of Science ®Google Scholar
• Bacon O, Lum P, Hahn J, et al. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis 2006; 33: 228–234
   PubMed Web of Science ®Google Scholar
• Brecht M L, O'Brien A, von Mayrhauser C, Anglin M D. Methamphetamine use behaviors and gender differences. Addict Behav 2004; 29: 89–106
   PubMed Web of Science ®Google Scholar
• Davidson P J, McLean R L, Kral A H, Gleghorn A A, Edlin B R, Moss A R. Fatal heroin-related overdose in San Francisco, 1997 – 2000: a case for targeted intervention. J Urban Health 2003; 80: 261–273
   PubMed Web of Science ®Google Scholar
• Tyndall M W, Craib K J, Currie S, Li K, O'Shaughnessy M V, Schechter M T. Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr 2001; 28: 351–357
   PubMed Web of Science ®Google Scholar
• Bogart L M, Kral A H, Scott A, et al. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sex Transm Dis 2005; 32: 27–34
   PubMed Web of Science ®Google Scholar
• Lorvick J, Martinez A, Gee L, Kral A H. Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health 2006; 83: 497–505
   PubMed Web of Science ®Google Scholar